Chengdu, China

Yongzhe Xiang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yongzhe Xiang: Innovator in Pharmaceutical Chemistry

Introduction

Yongzhe Xiang is a notable inventor based in Chengdu, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical use. With a total of 3 patents, his work focuses on addressing critical health issues through advanced chemical formulations.

Latest Patents

Yongzhe Xiang's latest patents include a complex of angiotensin receptor antagonist and neutral endopeptidase inhibitor. This invention provides a complex represented by a specific formula, which is designed to treat chronic heart disease using a medicament that includes this complex. Another significant patent involves a pyridine derivative, which is a class of compounds containing lactam. This derivative serves as a Factor Xa inhibitor and is intended for use in the preparation of anticoagulant drugs, particularly for preventing or treating thrombosis or embolism.

Career Highlights

Throughout his career, Yongzhe Xiang has worked with prominent companies such as Chengdu Easton Biopharmaceuticals Co., Ltd and Chengdu Easton Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his innovative ideas in pharmaceutical chemistry.

Collaborations

Yongzhe has collaborated with notable coworkers, including Ying Wang and Guodong Cen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yongzhe Xiang stands out as an influential inventor in the pharmaceutical field, with a focus on creating innovative solutions for health challenges. His contributions through patents and collaborations highlight his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…